MikroScore
Science-backed ingredient evidence
Moderate Evidence Safety: Use with caution Study dose: 100 mg/day

5-HTP (5-Hydroxytryptophan)

Also known as: 5-Hydroxytryptophan, 5HTP, Griffonia simplicifolia, Serotonin-Vorläufer

Summary Moderate Evidence

5-HTP is a serotonin precursor crossing the blood-brain barrier. Used for sleep and mood. Critical: avoid with SSRIs or MAO inhibitors due to serotonin syndrome risk.

EU Health Claims: No approved claims

No EFSA health claims approved for 5-HTP. Available as a dietary supplement from Griffonia simplicifolia in the EU. Not an approved medication in Germany for psychiatric indications (unlike, for example, in Switzerland). Regulatory grey zone between supplement and pharmaceutical.

AI Summary

Quick verdict

5-HTP is a serotonin precursor crossing the blood-brain barrier. Used for sleep and mood. Critical: avoid with SSRIs or MAO inhibitors due to serotonin syndrome risk.

What the evidence supports

Several RCTs show improvements in depression, sleep, and appetite regulation. The mechanism (serotonin synthesis) is relatively well-understood.

What is NOT supported

Long-term safety and rare adverse effects in humans remain insufficiently studied.

EU/EFSA status

Not approved. No EFSA health claims approved for 5-HTP. Available as a dietary supplement from Griffonia simpli…

Safety

Use with caution

This AI summary is generated from the structured data on this page.

What is 5-HTP?

5-Hydroxytryptophan (5-HTP) is an amino acid that serves as a direct precursor to serotonin. It is synthesized from L-tryptophan (obtained from food) and represents the final step before serotonin is produced in the body.

Unlike L-tryptophan, 5-HTP crosses the blood-brain barrier efficiently, without competition from other amino acids. This makes it a more researched supplement for raising serotonin levels in the brain.

Serotonin itself cannot cross the blood-brain barrier—which is why dietary serotonin or peripheral serotonin has no central nervous system effects. This is the biochemical basis for 5-HTP supplementation: by providing the immediate precursor directly, we can potentially increase central nervous system serotonin synthesis.

Mechanism of Action

L-Tryptophan (from food)
    ↓ Tryptophan hydroxylase
5-HTP (this is where the supplement acts)
    ↓ Aromatic L-amino acid decarboxylase
Serotonin (5-HT)
    ↓ N-acetyltransferase
Melatonin

5-HTP can increase both serotonin and melatonin levels—which explains potential effects on mood and sleep. The same enzyme that converts 5-HTP to serotonin is active throughout the brain and periphery, including in the pineal gland, where melatonin synthesis occurs.

What Does the Research Actually Say?

Established Evidence (Older, Methodologically Limited RCTs)

  • Depression symptoms: A direct RCT comparison with fluoxamine showed comparable efficacy, though the sample size was small. This is one of the few direct head-to-head comparisons with an SSRI in the literature.
  • Sleep: REM sleep duration increased in several studies, and sleep latency (time to fall asleep) was shortened in some trials. The data suggest mild sleep-promoting effects.
  • Fibromyalgia: Pain reduction was observed in multiple small RCTs, though these studies are now 20–30 years old.
  • Appetite and weight: Studies reported reduced satiety signals and lower caloric intake in RCTs, though most used very small sample sizes (n=20–30).

Important Limitations

  • Most studies date from the 1980s–2000s with small sample sizes
  • No modern, large-scale RCTs exist
  • Many studies were industry-funded
  • Publication bias likely favors positive results
  • Few studies controlled for placebo effects rigorously

Not Established

  • Anti-aging or longevity endpoints
  • Efficacy as a replacement for clinical treatment of depression
  • Long-term safety beyond 12–16 weeks of continuous use
  • Comparative efficacy vs. L-tryptophan (direct comparison studies are lacking)

The Critical Safety Warning

5-HTP carries a real interaction risk that many users underestimate:

Serotonin Syndrome can occur when combined with:

  • SSRIs (fluoxetine, sertraline, escitalopram, paroxetine, citalopram, etc.)
  • SNRIs (venlafaxine, duloxetine, desvenlafaxine)
  • MAO inhibitors (tranylcypromine, phenelzine, moclobemid)
  • Tramadol (opioid analgesic with serotonergic activity)
  • Triptans (migraine medications like sumatriptan, rizatriptan)
  • Lithium (mood stabilizer—enhances serotonergic transmission)
  • Linezolid (antibiotic with MAOI activity)

Serotonin syndrome is a potentially life-threatening condition characterized by:

  • Hyperthermia (dangerous elevation in body temperature)
  • Agitation and confusion
  • Tremor and muscle rigidity
  • Seizures
  • Cardiovascular instability

If you take any of these medications, do not use 5-HTP without first consulting your physician.

Mechanism of the Interaction

5-HTP bypasses the first enzymatic step and directly elevates serotonin. When combined with drugs that block serotonin reuptake (SSRIs) or block its degradation (MAOIs), serotonin can accumulate to toxic levels in the synapse. This is not a theoretical risk—case reports in the medical literature document serotonin syndrome from 5-HTP combinations.

Is 5-HTP Safe?

At doses of 50–200 mg/day for short-term use (≤12 weeks), and in people not taking serotonergic medications, 5-HTP is possibly safe, but should be approached with caution.

Common Side Effects

  • Nausea (especially at doses >150 mg or when first starting)
  • Diarrhea and loose stools
  • Decreased appetite (paradoxically, despite its use for appetite control)
  • Mild stomach upset
  • Headaches in some users

Most side effects diminish after 1–2 weeks of use.

Long-Term Safety

This is poorly studied. There are no long-term safety trials in humans beyond 16 weeks. Concerns about chronic serotonin elevation:

  • Potential for tachyphylaxis (tolerance development)
  • Possible effects on heart valve function (serotonin can affect cardiac tissue—though 5-HTP appears lower risk than fenfluramine)
  • Endocrine effects: high serotonin might suppress cortisol or affect sex hormone pathways (speculative, not well-studied)

Recommendation: Do not take 5-HTP continuously for months without medical supervision. Use intermittently or in cycles (e.g., 4–6 weeks on, 1–2 weeks off).

Who Should Avoid 5-HTP

  • Anyone taking SSRIs, SNRIs, MAOIs, tramadol, or triptans
  • Pregnant or breastfeeding women (limited safety data)
  • Individuals with history of cardiac valve disease
  • People with uncontrolled hypertension
  • Carcinoid syndrome patients (5-HTP use can trigger carcinoid crisis)

Comparison to L-Tryptophan

Both are serotonin precursors, but operate at different steps:

  • L-Tryptophan: First step (converted to 5-HTP by tryptophan hydroxylase). Shares transport across the blood-brain barrier with other large neutral amino acids—less reliable CNS entry.
  • 5-HTP: Directly converted to serotonin. Better blood-brain barrier penetration but lacks direct head-to-head comparison in modern RCTs.

The choice between them depends on individual tolerance and the strength of desired effect.

Summary and Evidence Grade

Evidence Level: 2 (Moderate evidence from older RCTs, limited modern data)

5-HTP has biochemical plausibility and shows modest efficacy in older clinical trials for depression, sleep, and appetite regulation. However, the evidence base is aging, studies are small, and no modern large-scale RCTs exist. Most importantly, the serotonin syndrome risk is real and non-theoretical, making 5-HTP unsuitable for anyone already taking serotonergic medications.

If you are not on serotonergic drugs and wish to trial 5-HTP for sleep or mood support, doses of 100–200 mg/day for up to 12 weeks can be considered, with close attention to side effects. Do not combine with any serotonergic medication without explicit medical clearance.

Key Studies

Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan

Turner et al. (2006)

Review: 5-HTP crosses the blood-brain barrier efficiently and increases central nervous system serotonin synthesis. Clinical studies show antidepressive efficacy comparable to fluoxamine in one RCT.

PubMed PMID 16023217

5-Hydroxytryptophan: a clinically-effective serotonin precursor

Birdsall TC (1998)

Review of clinical data: 5-HTP studied for depression symptoms, sleep problems, fibromyalgia, and obesity in RCTs. Clear warning: do not combine with MAO inhibitors or SSRIs due to serotonin syndrome risk.

PubMed PMID 9727088

Effects of 5-hydroxytryptophan on the sleep of normal human subjects

Wyatt et al. (1971)

RCT: 5-HTP was associated with increased REM sleep duration and improved sleep quality. Provides basis for 5-HTP's use in sleep optimization.

PubMed PMID 4105646

Dietary supplements and depression

Perez-Cornago A et al. (2017)

Review: Among herbal supplements, 5-HTP shows the most consistent antidepressive evidence, with moderate effect sizes in multiple studies from the 1990s to 2000s.

PubMed PMID 28077136
Editorial notice: For most ingredients described here, no health claims are approved in the EU (Regulation (EC) 1924/2006). Evidence levels are editorial assessments of research quality — not health promises. This content is not a substitute for medical advice and does not constitute a recommendation to treat, alleviate, or prevent any disease.